Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Neuroscientific Biopharmaceuticals Ltd. ( (AU:NSB) ) just unveiled an update.
NeuroScientific Biopharmaceuticals Limited announced the cessation of Anthony Keating as a director, effective June 26, 2025. This change in the board may influence the company’s strategic direction and stakeholder interests, particularly in its ongoing efforts to advance treatments for neurodegenerative diseases.
More about Neuroscientific Biopharmaceuticals Ltd.
NeuroScientific Biopharmaceuticals Limited operates in the biopharmaceutical industry, focusing on the development of therapeutic products targeting neurodegenerative conditions.
Average Trading Volume: 428,090
Technical Sentiment Signal: Buy
Current Market Cap: A$13.01M
For detailed information about NSB stock, go to TipRanks’ Stock Analysis page.